DE602005021750D1 - Impfstoffe mit lawsoniaintrazellularis-untereinheit - Google Patents

Impfstoffe mit lawsoniaintrazellularis-untereinheit

Info

Publication number
DE602005021750D1
DE602005021750D1 DE602005021750T DE602005021750T DE602005021750D1 DE 602005021750 D1 DE602005021750 D1 DE 602005021750D1 DE 602005021750 T DE602005021750 T DE 602005021750T DE 602005021750 T DE602005021750 T DE 602005021750T DE 602005021750 D1 DE602005021750 D1 DE 602005021750D1
Authority
DE
Germany
Prior art keywords
relates
vaccines
lawsonia intracellularis
lawsonia
cellularis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602005021750T
Other languages
English (en)
Inventor
Paul Vermeij
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Intervet International BV
Original Assignee
Intervet International BV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Intervet International BV filed Critical Intervet International BV
Publication of DE602005021750D1 publication Critical patent/DE602005021750D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Virology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DE602005021750T 2004-01-22 2005-01-18 Impfstoffe mit lawsoniaintrazellularis-untereinheit Active DE602005021750D1 (de)

Applications Claiming Priority (10)

Application Number Priority Date Filing Date Title
EP04100208 2004-01-22
EP04100203 2004-01-22
EP04100205 2004-01-22
EP04100209 2004-01-22
EP04100204 2004-01-22
EP04100211 2004-01-22
EP04100210 2004-01-22
EP04100206 2004-01-22
EP04100202 2004-01-22
PCT/EP2005/000562 WO2005070958A2 (en) 2004-01-22 2005-01-18 Lawsonia intracellularis subunit vaccines

Publications (1)

Publication Number Publication Date
DE602005021750D1 true DE602005021750D1 (de) 2010-07-22

Family

ID=34812485

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602005021750T Active DE602005021750D1 (de) 2004-01-22 2005-01-18 Impfstoffe mit lawsoniaintrazellularis-untereinheit

Country Status (12)

Country Link
US (1) US8025884B2 (de)
EP (1) EP1709067B1 (de)
JP (1) JP2007537721A (de)
KR (1) KR20060134054A (de)
AT (1) ATE470673T1 (de)
AU (1) AU2005206291B2 (de)
BR (1) BRPI0507017A (de)
CA (1) CA2554472A1 (de)
DE (1) DE602005021750D1 (de)
DK (1) DK1709067T3 (de)
MX (1) MXPA06008217A (de)
WO (1) WO2005070958A2 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY146476A (en) 2004-06-24 2012-08-15 Boehringer Ingelheim Vetmed Method of diagnosing lawsonia intracellularis
US8834891B2 (en) 2005-03-14 2014-09-16 Boehringer Ingelheim Vetmedica, Inc. Immunogenic compositions comprising Lawsonia intracellularis
US8398994B2 (en) 2005-07-15 2013-03-19 Boehringer Ingelheim Vetmedica, Inc. Lawsonia vaccine and methods of use thereof
US8470336B2 (en) 2006-05-25 2013-06-25 Boehringer Ingelheim Vetmedica, Inc. Vaccination of young animals against Lawsonia intracellularis infections
US8398970B2 (en) 2007-09-17 2013-03-19 Boehringer Ingelheim Vetmedica, Inc. Method of preventing early Lawsonia intracellularis infections
TWI551295B (zh) 2008-04-18 2016-10-01 英特威特國際股份有限公司 防備胞內勞森菌(Lawsonia intracellularis)用疫苗
TWI449533B (zh) 2008-04-18 2014-08-21 Intervet Int Bv 防備胞內勞森菌(Lawsonia intracellularis)、豬肺炎黴漿菌(Mycoplasma hyopneumoniae)及豬環狀病毒(Porcine circo virus)用疫苗
JP5723772B2 (ja) * 2008-07-22 2015-05-27 インターベット インターナショナル ベー. フェー. 新規血清型のローソニア・イントラセルラリス細菌、その細菌に基づくワクチン、該新規ローソニア・イントラセルラリス血清型の特定に適した抗体および該抗体を製造するためのハイブリドーマ
US8784829B2 (en) 2008-10-23 2014-07-22 Intervet Inc. Lawsonia intracellularis vaccines
US20140017268A1 (en) * 2012-06-05 2014-01-16 Regents Of The University Of Minnesota Composition and Methods for Detecting or Preventing Lawsonia intracellularis Infections
CA2931137C (en) 2013-12-03 2023-03-14 Intervet International B.V. Vaccine against porcine circo virus type 2
US10751405B2 (en) 2015-02-04 2020-08-25 Intervet Inc. Vaccine for use against subclinical Lawsonia infection in a pig
WO2016124623A1 (en) 2015-02-04 2016-08-11 Intervet International B.V. A vaccine for use against subclinical lawsonia infection in a pig
CA3131800A1 (en) * 2019-02-28 2020-09-03 University Of Saskatchewan Lawsonia intracellularis compositions and methods of using the same
KR102249189B1 (ko) * 2020-01-09 2021-05-07 전북대학교 산학협력단 항원성이 증진된 항원을 발현하는 약독화된 살모넬라 변이주를 유효성분으로 포함하는 돼지 증식성 회장염 및 살모넬라증 동시 예방 또는 치료용 백신 조성물
CN112940089B (zh) * 2021-01-27 2022-09-09 湖南康保特生物科技有限公司 胞内劳森菌flgE重组蛋白及胞内劳森菌抗体检测试剂盒
CN117229421B (zh) * 2023-10-23 2024-05-31 扬州大学 非洲猪瘟病毒外囊膜蛋白CD2v胞外区靶标抗原特定表位及其抗体和应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5885823A (en) 1995-06-05 1999-03-23 Nobl Laboratories, Inc. Lawsonia intracellularis cultivation, anti-Lawsonia intracellularis vaccines and diagnostic agents
WO2000069903A1 (en) 1999-05-13 2000-11-23 Pfizer Products Inc LAWSONIA DERIVED GENE AND RELATED SodC POLYPEPTIDES, PEPTIDES AND PROTEINS AND THEIR USES
EP1094070A3 (de) * 1999-10-22 2002-01-09 Pfizer Products Inc. Lawsonia intracellularis Proteine sowie Methoden und Materialien die diese verwenden
JP2004529854A (ja) * 2000-09-29 2004-09-30 アリゾナ・ボード・オブ・リージエンツ・オン・ビハーフ・オブ・ザ・ユニバーシテイー・オブ・アリゾナ 増殖性回腸炎のための改善されたワクチン及びその作製と使用の方法
DK1586646T3 (da) * 2000-12-20 2011-06-27 Intervet Int Bv Lawsonia intracellularis-vaccine
CA2501238A1 (en) * 2002-10-04 2004-04-22 Regents Of The University Of Minnesota Nucleic acid and polypeptide sequences from lawsonia intracellularis and methods of using

Also Published As

Publication number Publication date
CA2554472A1 (en) 2005-08-04
DK1709067T3 (da) 2010-10-11
MXPA06008217A (es) 2007-05-23
BRPI0507017A (pt) 2007-06-05
KR20060134054A (ko) 2006-12-27
AU2005206291A1 (en) 2005-08-04
US20090053228A1 (en) 2009-02-26
WO2005070958A3 (en) 2005-11-24
JP2007537721A (ja) 2007-12-27
EP1709067A2 (de) 2006-10-11
ATE470673T1 (de) 2010-06-15
EP1709067B1 (de) 2010-06-09
AU2005206291B2 (en) 2010-06-03
US8025884B2 (en) 2011-09-27
WO2005070958A2 (en) 2005-08-04

Similar Documents

Publication Publication Date Title
DE602005021750D1 (de) Impfstoffe mit lawsoniaintrazellularis-untereinheit
ATE330013T1 (de) Lawsonia intracellularis impfstoff
WO2006056480A3 (en) Means and methods for detecting methylated dna
DE602004024423D1 (de) Impfstoff mit lawsonia intracellularis-untereinheit
CL2012002900A1 (es) Secuencias de acido nucleico procedente de un virus causante del sindrome de miocardiopatia (cms) en peces; vector; celula huesped; vacuna de adn; proteina recombinante codificada; vacuna recombinante; inmunoensayo para la deteccion de dicho virus; kit de diagnostico; y uso de las mismas.
UA103885C2 (en) Immunogenic streptococcus proteins
WO2003058248A3 (en) Diagnostics and vaccines for mycrobacterium paratuberculosis infections
RU2012137304A (ru) Рекомбинантные белки для применения в вакцине, антитела к указанным белкам и диагностические и терапевтические способы, включающие указанное
WO2003095480A3 (en) Brachyspira hyodysenteriae vaccine
WO2004007726A3 (en) Brachyspira hyodysenteriae vaccine
ZA200602107B (en) Piroplasmid vaccine
NO20081541L (no) Ny sjo-lus vaksine
DE602005018021D1 (de) Impfstoffe mit ornithobakterium rhinotracheale-untereinheit
BRPI0417440A (pt) ácido nucleico, fragmento e molécula de dna, veìculo recombinante vivo, célula hospedeira, proteìna de lawsonia intracellularis, vacina para combater as infecções com lawsonia intracelularis, método para a preparação de uma vacina, e, testes de diagnóstico para aldetecção de anticorpos contra lawsonia intracellularis e material antigênico de lawsonia intracellularis
TH62170A (th) วัคซีนเชื้อก่อโรค Lawsonia intracellularis
PT1176192E (pt) Vacina de helicobacter felis
RU2008126239A (ru) Поливалентный химерный вакциноген и диагностический антиген ospc
WO2008076490A3 (en) Histophilus somni antigens, compositions and methods of use
TH88495B (th) วัคซีนชนิดใหม่สำหรับปรสิตทางทะเล